Bentham Science Logo

Contents

Current Drug Targets, Volume 16 - Number 11


Editorial


Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?

, 16(11): 1165 - 1171

Luisella Pirozzi, Petros Sountoulides, Pietro Castellan, Fabrizio Presicce, Riccardo Lombardo, Marilena Romero, Cosimo De Nunzio, Andrea Tubaro, Luigi Schips and Luca Cindolo


DOI: 10.2174/1389450116666150518101617




PDE-5 Inhibitors for BPH-Associated LUTS

, 16(11): 1180 - 1186

Philip Brousil, Majid Shabbir, E. Zacharakis and Arun Sahai


DOI: 10.2174/138945011611151013164756




The Current Indications and the Benefits of Combining a β3-Agonist with an Anticholinergic for the Treatment of OAB

, 16(11): 1198 - 1206

Cosimo De Nunzio, Fabrizio Presicce, Luisella Pirozzi, Pietro Castellan, Luigi Schips, Luca Cindolo, Riccardo Lombardo and Andrea Tubaro


DOI: 10.2174/1389450116666150806124345




Cancer Kinases and its Novel Inhibitors: Past, Present and Future Challenges

, 16(11): 1233 - 1245

Prathesha Pillai, R.S. Surenya, Shantikumar V. Nair and Vinoth-Kumar Lakshmanan


DOI: 10.2174/1389450116666150416120108



Loop Diuretics Strategies in Acute Heart Failure: From Clinical Trials to Practical Application

, 16(11): 1246 - 1253

Alberto Palazzuoli, Gaetano Ruocco, Marco Pellegrini, Matteo Beltrami, Gabriele Del Castillo and Ranuccio Nuti


DOI: 10.2174/1389450116666150420125531



Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation

, 16(11): 1254 - 1269

Hans Hendrik Schafer, Thomas Dieterle, Aaron Trachsler, Mikael Gencay and Edelgard Anna


DOI: 10.2174/1389450116666150408103806




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science